Intelligence Brief

The CLEARED
Intelligence Brief

Issue 001  |  April 01, 2026

What happened this week in AI and health practice governance.

What it means for your practice.

What to do about it.

AI is entering health practice faster than governance frameworks are keeping up. The FDA is reducing oversight. Hospital systems are pushing AI into diagnostic roles without clinical review protocols. The WHO is raising alarms. Practitioners who can document what AI touches, when, and what they did with its output will be differentiated from those who cannot.

Signal 1

CEO of America's Largest Public Hospital System Says He Is Ready to Replace Radiologists with AI

NYC Health + Hospitals CEO Mitchell Katz told reporters this week that the system is exploring using AI to read diagnostic imaging without radiologist review. The medical community's response was immediate and sharp. One physician summarized it: "Some of you may die, but that is a sacrifice I am willing to make." The r/medicine thread drew over 800 upvotes and 353 comments, nearly all opposing the move.

What this means for you

This is the exact pattern CLEARED was built to name. When a system operator decides AI output is "good enough" without clinical oversight, the handoff between AI and patient becomes invisible. If the largest public hospital system in the country is making this calculation, smaller practices need to understand where their own handoff points are. The question is not whether AI is accurate. The question is who is accountable when it is not.

Signal 2

FDA Relaxes Oversight of AI Health Software and Clinical Decision Support Tools

In January 2026, the FDA published updated guidance that reduces regulatory oversight of certain AI-enabled clinical decision support software and wellness wearables. The key shift: software that provides recommendations a clinician can "independently review and understand" no longer requires FDA device clearance. This applies to generative AI systems that produce a single recommendation for practitioner review.

What this means for you

The FDA just widened the space for AI tools in clinical practice while narrowing the definition of what it will regulate. That means more AI tools will enter your workflow with less federal oversight. The responsibility shifts to you. If you are using any AI tool that touches client recommendations, intake, or clinical notes, the governance burden is now on your practice, not on the tool manufacturer.

Signal 3

WHO Convenes Global Consortium on Responsible AI in Mental Health

On March 17-19, the World Health Organization convened consortium members at TU Delft to align shared priorities for responsible AI adoption in health. Their position: generative AI tools used for mental health support are "neither designed nor tested for mental health, and pose potentially serious risks." The APA followed with a health advisory on AI chatbots in wellness applications, noting that AI "cannot replace a trained clinician."

What this means for you

The international health community is drawing a line. If you are a health coach or integrative practitioner using AI for any aspect of client interaction, the global standard is moving toward requiring human oversight. "The AI helped me" is not a governance position. "I verified the AI output against my clinical judgment" is.

Signal 4

Penn State Research Shows AI in Clinical Workflows Lowers Perceived Liability. It Does Not Eliminate It.

A March 2026 Penn State study found that integrating AI into clinical workflows can lower perceived liability exposure for practitioners. However, the legal reality is unchanged: physicians and practitioners remain "squarely on the hook for clinical judgment." The standard of "reasonable care" is shifting. It may soon be measured by what an AI system could have detected or prevented.

What this means for you

This signal cuts both ways. AI can make your practice more defensible, but only if you can demonstrate you governed it properly. An unaudited AI workflow is not a liability shield. It is a liability amplifier. If you cannot document what AI touched, when, and what you did with its output, you are exposed.

The Pattern

The trajectory is clear: AI is entering health practice faster than governance frameworks can keep up. The FDA is stepping back. Hospital systems are pushing forward. The WHO is raising alarms. And the legal system is still figuring out who to hold accountable when something goes wrong. What this means for practitioners who are paying attention: the window between "AI is optional" and "AI is expected" is closing. The practitioners who can demonstrate they governed their AI integration thoughtfully will be differentiated from those who either avoided it entirely or adopted it without guardrails. Both extremes carry risk. The middle path is governance.

One Thing You Can Do This Week

Open your practice software, your intake forms, your note-taking tools. Ask one question: does any AI touch this? Most practitioners cannot answer with certainty. That uncertainty is your starting point. Write down every tool you use. Mark the ones you know use AI. Mark the ones you are not sure about. That list is the beginning of your audit.

Last updated: 2026-04-01

Get this in your inbox every Monday.

Signal tracking for practitioners who are paying attention.

Subscribe via LinkedIn Newsletter →

Missed an issue? Read every prior brief in the archive →

← All Issues